Golden
OrbiMed

OrbiMed

U.S-based venture capital and private equity firm investing on life sciences companies worldwide.

All edits by  Dawson Sewell 

Edits on 22 Mar 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 22 Mar 2019 4:52 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, India; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for ImaraImara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 19 Mar 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 Mar 2019 10:46 pm
Edits made to:
Article (+6/-6 characters)

Article

OrbiMed focuses on funding companies in the field of life sciences. The firm invests globally, with past investments on companies based in North America, EuropeEurope, and Asia (China, India, and Israel). The firm finances companies at various stages of development, from seed to buyouts. Its most recent funding round raised $551 million on September 2017.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 Mar 2019 10:45 pm
Edits made to:
Article (+5/-5 characters)

Article

OrbiMed, also known as OrbiMed Advisors, is a private equity and venture capital firm established in 1989. The firm was founded by Carl L. Gordon and Sven H. Borho. Its headquarters is located in New York City, New York and it has additional offices in San Francisco, California; Mumbai, IndiaIndia; Shanghai, China; Herzliya, Israel and Hong Kong. As of March 2019, the firm is managing 152 companies in its current portfolio and has sold off its ownership in 205 companies. Its most recent investment was for Imara on March 2019, a company developing therapeutics for sickle cell disease treatment.

Edits on 2 Nov 2018
Dawson Sewell
Dawson Sewell edited on 2 Nov 2018 3:17 pm
Edits made to:
Infobox (+3 properties)
Description (+149 characters)
People (+35 cells) (+421 characters)
Companies (+245 cells) (+4053 characters)
Categories (+1 topics)
Topic thumbnail

OrbiMed

OrbiMed is a healthcare management fund specializing in biopharmaceuticals that is Headquartered in New York City, New York and was founded in 1989.

People

Name
Role
Related Golden topics

Carl Gordon

Managing Partner



Carter Neild

General Partner



Chau Knuong

Partner



David Wang

Partner



Geoffrey Hsu

General Partner



Jonathan Silverstein

Managing Partner



Jonathan Wang

Partner



Mathew Rizzo

Partner



Peter Thompson

Partner



Richard Klemm

Partner



Rishi Gupta

Partner



Scotland Stevens

General Partner



Scott Green

Partner



Sunny Sharma

Partner



Sven Borho

Managing Partner



Trevor Polischuk

Partner



William Sawyer

Partner



Companies

Company
CEO
Location
Products/Services

Adaptimmune





Biopharmaceuticals

Adicet Bio





Biopharmaceuticals

Adimab





Biopharmaceuticals

Aeglea Biotherapeutics





Biopharmaceuticals

Aerpio





Biopharmaceuticals

Alector





Biopharmaceuticals

Alpine Immune Sciences





Biopharmaceuticals

Applied Immune Technologies





Biopharmaceuticals

Arrys Therapeutics





Biopharmaceuticals

Arsanis Biosciences





Biopharmaceuticals

Arvinas





Biopharmaceuticals

Ascendis Pharma







Atox Bio





Biopharmaceuticals

Attenua





Biopharmaceuticals

Audentes Therepeutics





Biopharmaceuticals

Avedro





Biopharmaceuticals

Avitide





Biopharmaceuticals

Baili Pharmaceutical





Biopharmaceuticals

Balance Therapeutics





Biopharmaceuticals

Bellus Health





Biopharmaceuticals

Bharat Serums and Vaccines





Biopharmaceuticals

BioLineRx





Biopharmaceuticals

CBT Pharmaceuticals





Biopharmaceuticals

ChemomAb





Biopharmaceuticals

Cleave Biosciences





Biopharmaceuticals

Infobox

Categories

Dawson Sewell"Initial topic creation"
Dawson Sewell created this topic on 2 Nov 2018 2:31 pm
Edits made to:
Topic thumbnail

 OrbiMed

U.S-based venture capital and private equity firm investing on life sciences companies worldwide.

No more activity to show.